⚠️ Uptrend Under Pressure Severe risk · 99 · Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY) Full briefing → Jul 28
Simple research view

BSX · Boston Scientific Corporation

$44.20 latest stored close
Detected setup Flat Base

Watch · Quality 31/100

Ask about BSX

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

Scans / Health Technology / BSX

$BSX

Boston Scientific Corporation

Boston Scientific Corporation is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $66B.

Strong Sell · 12 Health Technology Medical Specialties stock Stage 4 · Declining Base 1 Data 1h 0m ago
$44.20 latest close
Council read · 6 methods

Watch — evidence is building

0 buyable · 3 watch · 3 avoid. Review the observed passes and blockers before reading the chart.

Earnings-risk mode

Pre-earnings setup

Wednesday, July 29, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

BSX-0.58%
Same completed session window ending 2026-06-25.
CatalystUnavailable Stock reactionNegative Sector reactionUnavailable Opening surgeUnavailable Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.
Price $44.20 Jun 25 close
52W High $109.50 -59.6%
52W Low $43.89
Wks Since High 39w
Base Depth -59.9%
Base B1
SMA 50 $53.49
SMA 200 $79.94
Avg Vol 20,624,494
RS Rank 0
RS vs High -65.4%
RS Slope -7.5% ▼
Grp Rank #48/64
ADR% 3.0%
ATR(14) $1.46 (3.3%)
Rel Vol (today) 0.96×
Vol Pace N/A
U/D Vol 0.31
A/D Days 8A / 14D
A/D Rating E
VDU Bars 0/10 d
Earnings tmrw
$43.89
$109.50 0%

BSX Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for BSX.

Create Free Account
Setup Quality D 0/7 signals
✗ Stage 4 · Declining ✗ Power Trend ✗ RS New High ✗ Trend 0/8 ✗ No Pattern ✗ CANSLIM 45.7 (D) ✗ Gatekeeper Base #1 (A)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$BSX · $44.20 · as of 2026-06-25 · multi-factor read
12
/ 100
Strong Sell

Trend · Daily / Weekly / Monthly

Daily ▼ Downtrend
Weekly ▼ Downtrend
Monthly ▼ Downtrend

Moving Averages

50-day$53.49 ↓
100-day$62.38 ↓
200-day$79.94 ↓
Bearish (50 < 200)

RSI (14)

Reading29.1 · Oversold

Oversold — sellers extended; a relief bounce is possible.

MACD (12/26/9)

StateImproving
Histogram+0.052

Improving — MACD crossed above its signal line but still below zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width8% · 14.2%

Near the lower band — under pressure or oversold.

Volume · Buyer vs Seller

Up/Down vol0.31 · Distribution
Rel volume0.96×

Distribution — volume is concentrated on down days; sellers dominate. Recent volume is easing versus its baseline.

Support & Resistance

R · $50.14swing level
R · $58.34swing level
R · $66.88swing level
Price · $44.20now
S · $43.8952-week low

Fibonacci · Downtrend swing

23.6%$57.34
38.2%$65.67
50.0%$72.40
61.8%$79.12
78.6%$88.70

Retracement resistance zones measured from the recent swing high down to the low.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for BSX — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Daily downtrendWeekly downtrendMonthly downtrendBelow 200-day MA50/200 bearishRSI oversold
Want this read in a legend's voice? 💬 Ask a Legend about BSX
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 3 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini D

Trend-template read: fails Price > 200-day MA (MA150 not stored).

Passing evidence
4. Not extended (≤5% above pivot)Measured as passing
4. Stop within 7–8% of entryMeasured as passing
Failing evidence
1.1 Price > 200-day MA (MA150 not stored)Price $44.20, MA200 $79.94
1.4 50-day MA > 200-day MA (MA150 not stored)MA50 $53.49, MA200 $79.94
2/12 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
S: Base tightness (ATR% ≤ 4.5%)ATR% 3.30%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+0.0% QoQ
L: RS rank ≥ 80Data unavailable
1/8 checks
Avoid
Weinstein D

Stage-analysis read: declining (Stage 4) is not an advancing Stage 2.

Passing evidence
No passing evidence available.
Failing evidence
Stage 2 (Advancing phase) confirmedStage 4 (Declining)
Price above 30-week MA (200-day proxy)Price $44.20 vs MA200 $79.94
0/6 checks
Watch
Livermore C

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$44.20
Detected patternFlat Base
Failing evidence
Volume vs average0.96x
Distance from 52-week high59.6% below high
2/5 checks
Watch
Darvas C

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$44.20
Detected patternFlat Base
Failing evidence
Volume vs average0.96x
Distance from 52-week high59.6% below high
2/5 checks
Watch
Wyckoff C

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$44.20
Detected patternFlat Base
Failing evidence
Volume vs average0.96x
Distance from 52-week high59.6% below high
2/5 checks
Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

🕯 Latest candle: Doji — Open and close nearly equal — indecision. After a strong move it can signal a pause or pending reversal; wait for confirmation.

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
36RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net -3 E
A: 12 D: 15 Net: -365 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini SEPA criteria · 1/7 met
D 1/7 SEPA
Separate score from the 8-point Trend Template (0/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ +0%
Revenue growth ≥20% YoY +20%
Gross margin ≥30% 69%
ROE ≥17% 15%
RS rating ≥80 (leadership) 0
Stage 2 uptrend (Weinstein) Stage 4
Within 25% of 52W high -59.6%

Method Playbook

📋 Trade it like Darvas EXACT LEVELS · PRO
Minervini O'Neil Livermore Weinstein Darvas Wyckoff
Darvas C · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the top of the active Darvas box near the high as the mechanical breakout boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require price to clear the box top with volume confirmation; movement inside the box remains observation, not a trigger.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the active box support or the canonical structural stop that proves the breakout failed.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: As higher boxes form, raise the stop beneath the newest confirmed box floor; the stop moves up only.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when price breaks the active box floor or decisively falls back through the breakout structure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
No active setup in the latest scan — showing last result from 29 days ago. Patterns may no longer be valid. Run a new scan →

Pattern Analysis (historical · 29d ago)

Flat Base ⚠ Not actionable yet
31.3 score
RS Score 0
Trend 0/8
CANSLIM 45.7* (D)
depth pct: 6.8 base days: 35 prior uptrend pct: 26.7 weekly close spread pct: 4.8 vol dried: ✓ validation reason: valid generic setup multi tf reason: weekly trend template 0/8 — not confirmed (needs ≥4/8)
Why This Setup?
Flat Base

Flat Base: 35d base, depth 6.8%, prior uptrend 27%. Pivot $108.94. | Weak trend (0/8) | High-confidence pattern (85%) | Readiness 41/100 (early) | CANSLIM 45.7 (D) | ⚠ Not actionable yet

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

0/7 universals met
Why these seven? → The Universal Edge

Minervini Trend Template

0/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $44.20 vs SMA150 $73.39 / SMA200 $79.94
SMA 150 above SMA 200 SMA150 $73.39 vs SMA200 $79.94
SMA 200 trending up Slope -5.82 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $53.49
Price above SMA 50 $44.20 vs SMA50 $53.49
30%+ above 52W low +0.7% from $43.89
Within 25% of 52W high -59.6% from $109.50
RS score above 70 RS 0

Fundamentals

52W Range
0%
Mkt Cap SEC
65.7B
EPS QoQ
0%
Rev YoY
+20%
ROE
15%
Gross Margin
69%
D/E
0.47
EPS TTM
$1.94
P/E TTM
22.8x
Float
1.5B
Insider
No Buy

Company

Legend AI snapshot
Boston Scientific Corporation
BSX · NYSE · Health Technology · Medical Specialties
$44.20latest close $65.7Bmarket cap 0RS rank 31setup score
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
D 45.7* CANSLIM * disqualified on C, M
C · Curr. EPS
55
A · Annual EPS
76
N · New Highs
40
S · Supply/Demand
80
L · Leader RS
0
I · Inst. Spons.
96
M · Market
0

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
0/8
W. RS
25
W. Support
$43.89
W. Resist
$100.90
Weekly Structure

Get the full picture on BSX

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial